Main image
Click to view image in fullscreen
![]()
Cardio-oncology Related to Heart Failure, An Issue of Heart Failure Clinics
Cardiotoxicity, and specifically LV dysfunction, remains the limiting factor for many anti-neoplastic agents. This title summarizes for the heart failure specialist the possible ways that chemotherapeutic agents might cause cardiotoxicity as well as the methods for detecting, treating and preventing cardiotoxicity.
840,00 DH
En stock
Cardiotoxicity, and specifically LV dysfunction, remains the limiting factor for many anti-neoplastic agents. This title summarizes for the heart failure specialist the possible ways that chemotherapeutic agents might cause cardiotoxicity as well as the methods for detecting, treating and preventing cardiotoxicity.
| ISBN / EAN | 9781455711017 |
|---|---|
| Auteur | Lenihan, Daniel (Professor of Medicine, Director, Cardio-Oncology Center of Excellence, Advanced Heart Failure, Clinical Research, Cardiovascular Division, Washington University in St. Louis, St. Louis Missouri) |
| Editeur | Elsevier Health Sciences |